FDA approves first new sunscreen ingredient in over 25 years
The US Food and Drug Administration on June 9 cleared bemotrizinol, a new sunscreen active ingredient, for the American market. As reported by STAT News, it is the first new sunscreen active ingredient approved in the United States since 1999, although the molecule has been sold in Europe for decades under names such as Tinosorb S and Parsol Shield.
Bemotrizinol is a chemical filter that absorbs photon energy across both the UVA and UVB bands, delivering broad-spectrum protection. It is photostable on the skin surface and helps preserve the structure of other active ingredients in the same formulation, improving both safety and usability.
American and European regulatory regimes have long operated very differently. The European Union assesses sunscreen ingredients in the cosmetic category, while the FDA treats them as over-the-counter drugs, demanding far more comprehensive clinical dossiers for new molecules. STAT News reports that this divergence is the main reason bemotrizinol waited 25 years for US approval despite its long European track record.
The FDA used the framework established by the 2020 CARES Act for sunscreen regulation rather than the pre-2014 monograph process. That act modernized the older monograph and created a more predictable approval pathway for over-the-counter products.
On the industry side, the decision opens a new design space for American formulators. Most existing US sunscreens have worked from a constrained palette of actives in terms of photostability and skin feel. Combining bemotrizinol with existing ingredients such as zinc oxide or avobenzone allows lighter-feeling formulations with no white cast.
Dermatologists stress that broad-spectrum UVA protection is especially important. UVA radiation penetrates the deeper dermis and is a major driver of photoaging and melanoma risk. STAT cites the American Academy of Dermatology welcoming the addition as a way to strengthen the protective palette.
The fact that the FDA had not approved a new active since 1999 has long been criticized by public-health experts and clinicians. In expert commentary cited by STAT, Yale University dermatologist Dr David Leffell said the decision is 'critical to catching up with modern sun-protection standards.'
It is not yet clear when manufacturers will bring new formulations to shelves. STAT reports that major chemical suppliers such as BASF and DSM-Firmenich plan to start supplying US customers within six to 12 months. Existing American brands are expected to refresh their formulations in parallel.
Other ingredients still in regulatory limbo include bisoctrizole, drometrizole trisiloxane and diethylamino hydroxybenzoyl hexyl benzoate — all approved in Europe and still awaiting FDA assessment. The bemotrizinol decision could accelerate those reviews as well.
Sunburn and skin cancer cost the American public health system billions of dollars each year. CDC figures indicate that the majority of skin-cancer cases are linked to sun-driven UV exposure. This is not medical advice; consult your dermatologist about skin health and product choices.
Read next
APOE2 Gene: How It May Protect the Brain From Alzheimer's
APOE2 is a naturally occurring variant of the APOE gene that has long been linked to a reduced risk of Alzheimer's disease, in contrast to the higher-risk APOE4 variant. New research suggests APOE2 may protect brain cells by limiting DNA damage and helping neurons recover from stress, offering scientists a possible template for future treatments.
Always Tired? 9 Surprising Reasons and What to Do About It
Feeling exhausted even after a full night's sleep is one of the most common complaints people bring to doctors, and it rarely comes down to a single cause. From bedroom air quality to diet and undiagnosed medical conditions, here are nine common reasons for persistent tiredness, each paired with a practical fix.
Merck Signs Voluntary Licensing Deals for Experimental HIV Prevention Pill
Merck has signed voluntary licensing agreements allowing generic manufacturers in lower-income countries to produce its experimental oral HIV prevention pill. The deals aim to speed access in high-burden countries while the drug remains under regulatory review, though approval timelines and production scale-up remain uncertain.
Senate panel advances bipartisan ultra-processed food warning label bill
A Senate committee has advanced a bipartisan bill that would require front-of-package warning labels on ultra-processed foods and restrict advertising of junk food to children. The measure brought together Republicans, some aligned with the 'Make America Healthy Again' movement, and Democrats who have long pushed for stricter food regulation. The bill now heads toward a full Senate vote.
Why heatwaves trigger anxiety, and how to cope with the stress
Extreme heat can take a measurable toll on mental health, with young people and women among the groups most at risk of feeling anxious or 'incredibly helpless,' according to research on heat and wellbeing. This guide explains why rising temperatures affect mood and anxiety, and sets out practical strategies for managing heat-related distress.